Quest Diagnostics to Sell HemoCue Diagnostic Products Business

Quest Diagnostics to Sell HemoCue Diagnostic Products Business

By: Latest Articles from Benzinga.com

Posted on January 16, 2013 at 07:17 AM EST

Quest Diagnostics (NYSE: DGX ) today announced that it plans to sell its HemoCue diagnostic products business, as part of the company's strategy to refocus on diagnostic information services. HemoCue develops, produces and markets point-of-care testing systems. As a result, Quest Diagnostics will report 2012 and 2011 results for

Related Stocks:

GBL INV HSE NewStar Financial, Inc. Quest Diagnostics, Inc.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates